Bird flu vaccine close to final approval
SAN FRANCISCO (KGO) -- A vaccine for a highly-dangerous strain of bird flu is one step away from final approval.
The vaccine, developed by GlaxoSmithKline, has won the support of an FDA advisory panel. The panel found the vaccine was effective and safe enough to use against the N5N1 avian flu. The strain is rare in humans, but very dangerous.
The World Health Organization says 608 people have been infected by the virus worldwide since 2003, more than half of them died.
Final FDA approval is expected later this year.
medical research, flu, health
- Teen survives flight from SJC to Hawaii in wheel well 16 min ago
- At least 10 arrested at "420" celebration in SF
- Good Samaritan pulls boy from water in San Leandro
- Divers recover more bodies from sunken ferry
- San Jose police standoff ends with armed man 49 min ago
- San Francisco officer dragged by suspect getaway car
- Fairfield resident killed, boy injured after shooting
- Santa Rosa crash causes massive power outage
- Highway 1 reopens after major injury crash
- Posey, Lincecum lead San Francisco Giants to 4-3 win
- Boxer Rubin 'Hurricane' Carter dies at 76
- Minimalists find happiness living with less
- weather: Bay Area weather forecast for Monday
- roundup: Fatal shooting in Concord; Piedmont landslide